2006
DOI: 10.1016/j.virol.2005.11.047
|View full text |Cite
|
Sign up to set email alerts
|

HIV-1 subtype C in vitro growth and coreceptor utilization

Abstract: Human immunodeficiency virus type 1 subtype C (HIV-1C) accounts for about 50% of all HIV infections in the pandemic and is the predominant subtype in the heavily burdened region of southern Africa. HIV-1C possesses unique genetic and phenotypic features that might be associated with biological differences compared to other subtypes. Here, we generated virus isolates from individuals at different stages of HIV-1C infection and investigated the chemokine receptor repertoire that the derived HIV-1C isolates may u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
41
2

Year Published

2008
2008
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(45 citation statements)
references
References 151 publications
2
41
2
Order By: Relevance
“…Prior studies have also found little or no CCR2b and CCR3 use by subtype C HIV-1. However, our findings differ somewhat from the previously reported infrequent use of GPR15 and CXCR6 in subtype C (1,6,9,38,39). Additional isolates will be needed to determine if the use of these molecules is widespread among certain cohorts or if it reflects particular biological properties linked to other aspects of pathogenesis.…”
Section: Discussioncontrasting
confidence: 96%
“…Prior studies have also found little or no CCR2b and CCR3 use by subtype C HIV-1. However, our findings differ somewhat from the previously reported infrequent use of GPR15 and CXCR6 in subtype C (1,6,9,38,39). Additional isolates will be needed to determine if the use of these molecules is widespread among certain cohorts or if it reflects particular biological properties linked to other aspects of pathogenesis.…”
Section: Discussioncontrasting
confidence: 96%
“…Up to 19% of these individuals carried X4/X4R5 dual-tropic viruses, with no significant differences with a control group of patients infected with clade B viruses. In other studies that included a larger number of samples from clades C and D, it was noted that clade C might less frequently harbor X4 viruses, even in late disease stages (8,16,20,24,31), while conversely, clade D could be X4 tropic more frequently (10,14). The small number of samples with these variants in our study precluded the examination of this aspect more appropriately.…”
Section: Discussionmentioning
confidence: 61%
“…33 Our findings established CCR5-utilizing variants in both plasma and tissue in all but two sequences; this is consistent with previous studies of HIV-1 subtype C infections showing minimal corrector switch from CCR5 to CXCR4 even in the context of late stage AIDS and coinfections such as pulmonary TB. 28 Phenotypic studies may be warranted since genotype does not always accurately predict coreceptor utilization and subtle differences in usage of CD4 and coreceptors have been noted with CSF-derived and other viral isolates. 34,35 Given the prominent role of macrophages in the anti-TB immune response we explored their composition in the granulomas and found evidence of HIV-infected macrophages.…”
Section: Discussionmentioning
confidence: 99%
“…Since key viral determinants of cell tropism and coreceptor usage are located within the env V3 loop, 28 we investigated whether there were V3 loop amino acid differences between plasma-derived and tissue-derived sequences ( Table 2). The biochemical properties (charge, size, hydrophobicity) at the amino acid positions determining the folding patterns of the V3 loop were similar and indicative of predominantly CCR5-utilizing variants in plasma and tissue.…”
Section: Analysis Of Viral Tropismmentioning
confidence: 99%